Begin GLP-1 starting at $112 for your first month. Get access now. No code required.
Designed to support long-term metabolic health and resilience. Through combined GLP-1 + GIP signaling at lower doses, microdosed tirzepatide helps reduce food noise, promote steady energy, and supports everyday mental clarity while minimizing side effects. Ideal for patients seeking sustainable health benefits over time.
If you’re interested in more intensive dosing or larger weight loss goals, learn more about our GLP-1 Advanced tirzepatide program.
Maximum bioavailability through subcutaneous injections. Experience rapid energy improvement, enhanced mental clarity, and cellular rejuvenation. 85% of patients choose injectable for faster, more dramatic results.
*Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate. This formulation is available only through prescription for patients with a demonstrated clinical need.
This compounded formulation is not FDA-approved and is intended solely for patients under active care of a licensed prescriber. It is compounded in accordance with federal Section 503A guidelines.
Experience longevity-aligned metabolic resilience with lower GLP-1 + GIP signaling.
Microdosing uses smaller doses that remain capped, rather than titrating toward higher maintenance levels, allowing your clinician to tailor pacing to your goals and tolerance.
A lighter weekly protocol that may help you feel satisfied sooner, reduce persistent cravings, and quiet “food noise” for some patients — without chasing extremes.
Improved glucose regulation may help reduce energy swings and brain fog, supporting more consistent energy levels and cognitive focus throughout the day.
Microdosing prioritizes comfort by reducing common gastrointestinal side effects such as nausea and bloating, allowing the body to adapt more gradually.
Medication delivered every 12 weeks with ongoing provider oversight and personalized guidance to support long-term metabolic health.
A quick, visual comparison of Core, Advanced, and Elite to guide your selection.
How lower, capped-dose GLP-1 + GIP signaling supports long-term metabolic resilience with improved tolerability.
Book ConsultationEngages both GLP-1 and GIP receptors at lower doses to support metabolic signaling, glucose regulation, and appetite communication without overwhelming the system.
Gradual receptor activation helps the body adapt over time, supporting steadier energy, improved glucose balance, and reduced metabolic stress.
Low-and-slow incretin activation supports pathways linked to long-term metabolic resilience, insulin sensitivity, and cellular health while prioritizing tolerability.
Our streamlined process gets you matched with the perfect program quickly and safely.
Our streamlined process gets you matched with the perfect program quickly and safely.
Our streamlined process gets you matched with the perfect program quickly and safely.
Work with licensed medical providers who understand your body and goals.
No hidden fees or surprise charges. Just clear, honest pricing from day one.
Get access to your care team, whenever you need it. From questions to progress check-in.
Work with licensed medical providers who understand your body and goals.
No hidden fees or surprise charges. Just clear, honest pricing from day one.
Get access to your care team, whenever you need it. From questions to progress check-in.
Microdosing refers to using smaller, capped doses of tirzepatide compared to standard titration schedules. Your clinician determines whether this approach is appropriate and how your dose is set.
Microdosing tirzepatide engages GLP-1 and GIP pathways at lower doses to support comfort, steady energy, and metabolic stability. Standard GLP-1 dosing typically uses higher doses to drive stronger appetite suppression and weight-loss outcomes
GLP-1 Microdosing tirzepatide is well suited for patients seeking metabolic support with greater comfort and control. It may be a good fit for those new to GLP-1 therapy, sensitive to higher doses, or interested in a lower-intensity, longevity-focused approach.
Response varies. Some patients may notice changes in appetite, cravings, or weight over time, while others may not. Microdosing is designed for subtle, sustainable support rather than rapid outcomes.
Not always — everyone responds differently. Lower doses may reduce the likelihood or intensity of side effects for some people, but it’s not guaranteed. Your clinician can adjust pacing based on your response.
If at any point during the onboarding process you are found ineligible for our formulation, Enhance.MD will provide a full refund of 100% of your initial payment.
